Devoir Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 0.20 M
- Company Age 20 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.07 M
- Satisfied Charges ₹ 2.10 M
- Revenue Growth 53.01%
- Profit Growth 71.02%
- Ebitda 296.88%
- Net Worth 15.68%
- Total Assets -2.86%
About Devoir Lifesciences
Devoir Lifesciences Private Limited (DLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 05 May 2004 and has a history of 20 years and nine months. Its registered office is in Ludhiana, Punjab, India.
The Corporate was formerly known as Excel Drugs Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹6.07 M. The company has closed loans amounting to ₹2.10 M, as per Ministry of Corporate Affairs (MCA) records.
Gagan Khurana and Harmeet Singh serve as directors at the Company.
Company Details
-
Location
Ludhiana, Punjab, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24230PB2004PTC047127
-
Company No.
047127
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 May 2004
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Devoir Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gagan Khurana
|
Director | 05-May-2004 | Current |
|
Harmeet Singh
|
Director | 05-May-2004 | Current |
Financial Performance of Devoir Lifesciences.
Devoir Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 53.01% increase. The company also saw a substantial improvement in profitability, with a 71.02% increase in profit. The company's net worth Soared by an impressive increase of 15.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Devoir Lifesciences?
In 2021, Devoir Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹6.07 M
₹2.10 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.61 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Dec 2023 | Hdfc Bank Limited | ₹3.03 M | Open |
| 03 Nov 2023 | Hdfc Bank Limited | ₹3.03 M | Open |
| 23 May 2015 | Others | ₹1.05 M | Satisfied |
| 23 May 2015 | Others | ₹1.05 M | Satisfied |
How Many Employees Work at Devoir Lifesciences?
Devoir Lifesciences has a workforce of 9 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Devoir Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Devoir Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
